Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Sonoma Pharmaceuticals, Inc.

Boulder, CO, US

Sonoma Pharmaceuticals, Inc. appears in FDA device records in Boulder, CO. FDA records list 24 510(k) clearances between and , no PMA records and one registered establishment. As of , FDA records show 6 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
24
PMA records
0
Recall records
6
Registered establishments
1

FDA records under these names

1 name

FDA records resolved to Sonoma Pharmaceuticals, Inc. carry these names as well, as FDA wrote them. Each is the firm named on a registration, a 510(k), a PMA, a recall or an enforcement report that was joined to this company on a shared FDA identifier or on a matching name.

  • Oculus Innovative Sciences, Inc.510(k), enforcement report, recall

510(k) clearance history

FDA records hold 24 510(k) clearances for Sonoma Pharmaceuticals, Inc. between 2005 and 2026. The busiest year on record is 2017, with 5. The most recent is 2026, with 1.

Clearances by year, as a table
510(k) clearance decisions for Sonoma Pharmaceuticals, Inc., by decision year
YearClearances
20052
20061
20092
20101
20111
20131
20142
20153
20162
20175
20181
20242
20261
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K261023Microdacyn Wound Irrigation SolutionFROSubstantially Equivalent
K240510Microdacyn HydrogelFROSubstantially Equivalent
K233399Microdacyn Wound Care SolutionFROSubstantially Equivalent
K173896Microcyn Antimicrobial HydrogelFROSubstantially Equivalent
K171935Alevicyn SG Antimicrobial GelFROSubstantially Equivalent
K172622Microcyn Antimicrobial Skin and Wound CleanserFROSubstantially Equivalent
K172851Microcyn Plus Antimicrobial Wound Care SolutionFROSubstantially Equivalent
K171727Hydrocleanse Antimicrobial Skin and Wound Care SolutionFROSubstantially Equivalent
K162217LOYONFROSubstantially Equivalent
K161034Microcyn Plus Wound Care SolutionFROSubstantially Equivalent
K153648Microcyn Plus Skin and Wound HydrogelFROSubstantially Equivalent
K152945Alevicyn SG Antipruritic GelFROSubstantially Equivalent
K152055Ceramax Skin Barrier CreamFROSubstantially Equivalent
K143590Alevicyn SG Antipruritic GelFROSubstantially Equivalent
K141352ENDOCYN ROOT CANAL IRRIGATION SOLUTIONKJJSubstantially Equivalent
K141012HYDROCLEANSE WOUND CARE SOLUTIONFROSubstantially Equivalent
K131672MICROCYN SCAR MANAGEMENT HYDROGELPFPSubstantially Equivalent
K102945PEDIACYN ATOPIC DERMATITIS HYDROGELFROSubstantially Equivalent
K093585MICROCYN SKIN AND WOUND HYDROGELFROSubstantially Equivalent
K090206OCULUS PURACYN ANTIMICROBIAL SKIN AND WOUND CLEANSERFROSubstantially Equivalent
K090725OCULUS MICROCYN WOUND GELFROSubstantially Equivalent
K060113DERMACYN WOUND CAREFROSubstantially Equivalent
K042729DERMACYN WOUND IRRIGATIONFROSubstantially Equivalent
K041161MICROCYN WOUND CARE DRESSINGFROSubstantially Equivalent

Registered establishments

FDA registered establishments for Sonoma Pharmaceuticals, Inc., with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
30045544093004554409Sonoma Pharmaceuticals, Inc.5445 Conestoga Ct Ste 150, Boulder, CO 80301 US2026

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-0763-2017Ceramax Skin Barrier Cream: NET WT 0.1 OZ (3 g professional sample - not for retail sale) Under the supervision of a health care professional, Ceramax is intended to be used as a topical skin care preparation to relieve and to manage the burning and itching associated with various dermatoses including atopic dermatitis, irritant contact dermatitis, radiation dermatitis, and other dry skin conditions, by maintaining a moist wound and skin environment. General and Plastic Surgery: Ceramax is intended to be used as a topical skin care preparation to relieve and to manage the burning and itching associated with various dermatoses including atopic dermatitis, irritant contact dermatitis, radiation dermatitis, and other dry skin conditions, by maintaining a moist wound and skin environment.Firm became aware that professional samples of Ceramax are not meeting stability standards set for the product.Class IITerminated
Z-0890-2013Atrapro Antipruritic Hydrogel, 1.5 oz gel tube, 4 Net wt/ 1.5 oz.. RX only, Professional Sample, Not for Sale. Pre-printed tube: MS31071, Shelf carton: PL51091-08 Atrapro Antipruritic HydroGel is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including radiation dermatitis and atopic dermatitis.Out of specification result - stability test failure of free available chlorine (FAC) which functions as a preservative for the hydrogel. The 13 month test result obtained was 4 ppm FAC and the stability specification is >10 ppm FAC.Class IITerminated
Z-0451-2012Microcyn Dermatology HydroGel, Spray , 4 oz and 1.76 oz. Provided Pain Relief, Relieve Itch, Reduces symptoms of inflammation due to irritation, Provide a protective shield against contamination. Antibiotic-free, steroid-free and biodegradable.. Oculus Innovative Sciences . Petaluma, CA 94954. Intended for use by health care professionals in management of wounds including itch and pain relief associated with dermal irritation, sore, injuries and ulcers or dermal tissue. Microcyn Skin and Wound hydrogel is intended for use on first and second degree burns, excluding wounds such as leg ulcers, pressure ulcers, diabetic ulcers, and for the management of mechanically or surgically debrided wounds.Unapproved drug claims and those not approved under 510K clearance.Terminated
Z-0450-2012Microcyn Dermatology Spray with germ killing Preservatives (Rx); 8 fl oz. 99.999% Reduction In-solution in 30 seconds. MRSA - Staphylococcus aureus VFR - Enterococcus faecalis Acinetobacter baumannii Pseudomonas aeruginosa. Microcyn Dermatology Spray has been evaluated by the USP <51> Antimicrobial Effectiveness Test and in Time Kill studies. It has demonstrated effectiveness by reducing the microorganisms listed below and passed the USP antimicrobial Effectiveness test for a Category 1 product. Safe to use around eyes, nose and mouth. Oculus Innovative Sciences . Petaluma, CA 94954. Intended for use by health care professionals in management via debridement of woundsUnapproved drug claims and those not approved under 510K clearance.Terminated
Z-0449-2012Puracyn OTC; Wound & Skin Care Solution with Preservatives; Sold in 8 fl oz (trigger spray and finder pump) and 16 fl oz pump with insert. Kills 99.99% of Staph, MRSA, Strep and other Infectious Germs in 30 seconds in solution. Does not contain Antibiotics, Steroids or Alcohol. -Cleans infected wounds in one step - Safe to use around eyes, nose, m mouth and open wounds - Accelerated healing of minor wounds by keeping the wound clean -Non-toxic and non-irritating. Manufactured by Oculus Innovative Sciences for Innovaycen, Inc. 3546 N. Riverside Ave. Rialto, CA 92377 Made in USA. Intended for OTC use for the management of skin abrasions, lacerations, minor irritations, cuts, and intact skin.Unapproved drug claims and those not approved under 510K clearance.Terminated
Z-0448-2012Microcyn Solution with Preservatives (Rx), 16.9 fl oz (500 mL) and 33.5 fl oz. (990 mL) Ingredients: Electrolyzed Water (99.97%) Sodium Chloride (NaCl) (230 mg/L) and preservatives: Sodium Hypochlorite (Na0Cl) (40 mg/L), Hypochlorous acid (H0CL) (30 mg/L) -Non Foaming -Does not contain antibiotics - Does not facilitate resistance - No known drug/treatment interactions or contraindications -laboratory proven in solution inactivation of bacteria, viruses, fungi and spores. Performance testing: Microcyn Solution with Preservatives has been evaluated by the USP <51> antimicrobial Effectiveness Test and in Time-Kill studies. It has demonstrated effectiveness by reducing the microorganisms listed below and passed the USP antimicrobial Effectiveness test for a category 1 product. Oculus Innovative Sciences' Petaluma, CA 94954. Intended to be used by health care professionals in the management in wounds.Unapproved drug claims and those not approved under 510K clearance.Terminated

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Sonoma Pharmaceuticals, Inc. edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain